Navigation Links
Gay capital reeling with rising HIV infection

The gay capital? of the world, San Francisco is now reeling under the shock waves of a rebound epidemic of HIV infection. In the past one-year the rate of infection has actually doubled in most areas and in some select high-risk pockets of gay men, who are also intra venous drug users, the rates are even higher. And what is the cause for this sudden spurt?

Hold your breath! The successful control of spread of HIV infection in the area has made the high risk gay men lower their guard and the virus has struck back with a vengeance. Aggressive prevention programmes, safe sex and sex education drives promoting condoms had all resulted in a sharp fall in incidence a few years ago. But now the ghost is back and it is vigorously claiming fresh victims at an alarming pace.

Health workers say the lackluster attitude of high-risk gay men is the main cause of this sudden spurt. There is very poor willingness to use condoms and the false sense of having outsmarted the AIDS virus has led to general feeling that people need not be careful anymore. This is the culprit behind the spurt, authorities say.

Known as the gay capital, San Francisco was the first few centers of the AIDS epidemic and more than half of the city?s gay men were positive in the 1980s. More than 18000 people have died of AIDS in San Francisco.
'"/>




Page: 1

Related medicine news :

1. Meningitis is rocking the capital again
2. Zagreb, capital of Croatia, affected by first bird flu case
3. A new and surprising insight on AIDS
4. Surprising Cystic Fibrosis Finding That Could Be A Helpful Treatment Option
5. Early rising from sleep can run in families
6. Research reports that c-section deliveries are rising
7. Infertility rate in UK men increasing at an alarming rate with numbers rising over 2.5 million
8. Strategies to prevent the rising tide of the epidemic of chronic diseases
9. Blood Pressure Levels Across The Globe Show Surprising Drop
10. Doctors Said – ‘Stop Pressurising NHS Advisory Bod’
11. Deodorising Products may be Harmful to the Lungs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/4/2016)... ... ... A new collaboration will give more researchers access to the largest and ... leader SAS will provide researchers worldwide with data management and analytics tools to explore ... , The DCRI and SAS share the goal of greater transparency and openness in ...
(Date:5/4/2016)... ... May 04, 2016 , ... All-Star ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
(Date:5/4/2016)... Dallas, Texas (PRWEB) , ... May 04, 2016 , ... ... cancer awareness in people across the United States. Dermatologist Dr. Ellen Turner is encouraging ... heed dermatology experts’ advice and focus on skin safety and health now and in ...
(Date:5/4/2016)... CA (PRWEB) , ... May 04, 2016 , ... Dr. ... offering wisdom tooth removal surgery at their office. Wisdom tooth removal, a common dental ... not always problematic, they often are improperly erupted, resulting in risks of complications. By ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic Naturals ... cellular and metabolic health. This synergistic combination of omega-3 fatty acids and potent ... 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). , ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... -- According to market research "Global Magnetic ... Demand Forecast to 2022 - Industry Insights by Architecture ... High Field, Low to Mid Field, and Ultra High ... Vascular, Breast, Pelvic and Abdomen, Cardiac, and Other)" P&S ... was valued at $5,351.7 million in 2015, and it ...
(Date:5/3/2016)... May 3, 2016 ... dass sie einen entscheidenden Meilenstein durch diese ... Aufruf zum Handeln, um Patientenresultate  bei Verdauungs- ... zu Fortschritten im Verständnis der Hepatischen Enzephalopathie ... Bewusstsein für Hepatische Enzephalopathie in der Öffentlichkeit ...
(Date:5/2/2016)...  Celsion Corporation (NASDAQ: CLSN ), an ... the first cohort of patients in its Phase ... combining GEN-1, the Company,s DNA-based immunotherapy, with the ... patients with advanced ovarian cancer who will undergo ... the first three patients dosed, GEN-1 plus standard ...
Breaking Medicine Technology: